Skip to content

Insider · CIK 0002114888

Jean-Pierre Enguent

officer

Files at LAES (SEALSQ Corp). First filing Sep 3, 2026, latest Oct 7, 2026.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $122k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

LAES: SEALSQ Corp

LAESOct 9, 2026 · close 2.11

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
9Weak
LAESsell10b5-1
SEALSQ Corp
$86k
35,000 shares
-100%+16% from low-68% from high
6Weak
LAESsell10b5-1
SEALSQ Corp
$36k
15,000 shares
-100%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Oct 5, 2026LAES
SEALSQ Corp
MOption exercise
Ordinary Shares10b5-1
+35,000$0.01$35035,0005 d ago
Oct 6, 2026LAES
SEALSQ Corp
SOpen-market sale
Ordinary Shares10b5-1
-35,000$2.46$86k05 d ago
Oct 5, 2026LAES
SEALSQ Corp
AGrant or award
Employee Stock Option Plan (right to buy)derivative10b5-1
+50,000$0.00$050,0005 d ago
Oct 5, 2026LAES
SEALSQ Corp
MOption exercise
Employee Stock Option Plan (right to buy)derivative10b5-1
-35,000$0.00$015,0005 d ago
Sep 1, 2026LAES
SEALSQ Corp
MOption exercise
Ordinary Shares10b5-1
+15,000$0.01$15015,00039 d ago
Sep 3, 2026LAES
SEALSQ Corp
SOpen-market sale
Ordinary Shares10b5-1
-15,000$2.40$36k039 d ago
Sep 1, 2026LAES
SEALSQ Corp
MOption exercise
Employee Stock Option Plan (right to buy)derivative10b5-1
-15,000$0.00$0039 d ago

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Jean-Pierre Enguent: insider trades and track record | InsiderTell